Moreover, plasma CCL20 levels were higher in patients with ADPKD (median and IQR: 6.0 (1.2–19.2) vs. 0.0 (0.0–9.0) pg/mL), p < 0.05 (Figure 4B). This evidence concerns the gene CCL20 and autosomal dominant polycystic kidney disease.